Navigation Links
Neuralstem Secures $8 Million In Debt Financing From Hercules
Date:3/25/2013

ROCKVILLE, Md., March 25, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced today that it secured $8 million in debt financing with Hercules Technology Growth Capital (NYSE: HTGC), to fund the company's capital budget through late 2014.

(Logo:  http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO)

"This debt financing extends our cash runway well into late 2014 at a critical time in our clinical product development cycle. We have multiple NSI-566 cell therapy clinical trials planned this year, building on our successful ALS Phase I trial, including the upcoming phase II ALS in the U.S.; both chronic and acute spinal cord injury in the U.S. and South Korea, respectively; ALS in Mexico, and stroke in China, in addition to completing the NSI-189/Phase Ib trial in major depressive disorder," said Neuralstem's President and CEO Richard Garr . "We are pleased to have the support of leading life sciences and technology investor, Hercules."

"Neuralstem's unique stem cell platform has the potential to address a serious unmet medical need in the ALS and spinal cord injury patient populations, as well as other indications. The team's progress to date is the result of years of meticulous research and development. We are proud to be a strong financial partner," said Chad Norman , managing director at Hercules.

The funding of $8 million, which closed on March 22, 2013, is in the form of a secured note which is repayable in installments over 42 months following an interest-only period of nine months and up to 12 months upon funding of a second tranche. The note bears interest at a prime-based variable rate. In add
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Neuralstem Grants Licenses For Central Nervous System Therapy Surgical Devices To Cedars-Sinai Medical Center
2. Neuralstem President And CEO To Present At BIO CEO & Investor Conference 2013
3. Neuralstem to Raise $7.0 Million in Registered Direct Offering
4. Neuralstem Announces Proposed Public Offering
5. Neuralstem Grants First Licenses For CNS Therapy Surgical Devices
6. Neuralstem Announces Exercise Of Entire Over-Allotment Option By Aegis Capital Corp.
7. Seventeenth Patient Dosed in Neuralstem ALS Stem Cell Trial
8. First Patients Dosed in Ib Phase of Neuralstems NSI-189 Trial in Major Depressive Disorder
9. Sixteenth Patient Dosed In Neuralstem ALS Stem Cell Trial
10. Neuralstem Updates ALS Stem Cell Trial Progress
11. Total Artificial Heart Manufacturer SynCardia Secures $19M Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 2015   DocResponse was ranked the ... a peer-reviewed study , "Evaluation of symptom ... published in the July issue of The British ... Medical School researchers determined that performance of online ... correct diagnosis first in standardized patient evaluations more ...
(Date:7/27/2015)... NAMUR , Belgium , July ... MKT: VNRX), a life sciences company focused on developing ... types and other conditions, today announced that it has ... research organization, Global Specimen Solutions, Inc. (GSS), to support ... colorectal cancer tests. Under the agreement, ...
(Date:7/27/2015)... , July 27, 2015 Research and Markets ... "Intraoperative Imaging Market by Type (Intraoperative CT, Intraoperative ... Asia-Pacific, ROW) - Global Forecast to 2019" report ... expected to reach a value of $2.1 Billion by ... of 3.5% during the forecast period. ...
Breaking Medicine Technology:Harvard Study Finds DocResponse Most Accurate Medical Symptom Checker/Diagnostics Application 2Harvard Study Finds DocResponse Most Accurate Medical Symptom Checker/Diagnostics Application 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 2VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 4VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 5VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 6VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 7Global Intraoperative Imaging (Intraoperative CT, Intraoperative MRI, Intraoperative Ultrasound) Market Forecasts & Trends 2015-2019 2
...  Integware today announced that it has signed a ... PLM Software, a leading global provider of product ... focused for nearly twenty years on extending PLM ... industry. Its platform-neutral development approach enables it to ...
... FLORHAM PARK, N.J., Jan. 25, 2012  Shionogi Inc., the ... announced results from two studies published online today in ... the first study, a randomized, double-blind, placebo-controlled phase III ... 3-16 with problem drooling due to neurologic conditions demonstrated ...
Cached Medicine Technology:Integware Announces Systems Integrator Agreement With Siemens PLM Software 2Study Data Show CUVPOSA® Reduced Chronic Severe Drooling in Patients Ages 3-16 Years-Old with Neurologic Conditions 2Study Data Show CUVPOSA® Reduced Chronic Severe Drooling in Patients Ages 3-16 Years-Old with Neurologic Conditions 3Study Data Show CUVPOSA® Reduced Chronic Severe Drooling in Patients Ages 3-16 Years-Old with Neurologic Conditions 4Study Data Show CUVPOSA® Reduced Chronic Severe Drooling in Patients Ages 3-16 Years-Old with Neurologic Conditions 5Study Data Show CUVPOSA® Reduced Chronic Severe Drooling in Patients Ages 3-16 Years-Old with Neurologic Conditions 6Study Data Show CUVPOSA® Reduced Chronic Severe Drooling in Patients Ages 3-16 Years-Old with Neurologic Conditions 7Study Data Show CUVPOSA® Reduced Chronic Severe Drooling in Patients Ages 3-16 Years-Old with Neurologic Conditions 8
(Date:7/28/2015)... Wilmington, DE (PRWEB) , ... July 28, 2015 , ... ... for 2015. Accounting Today’s annual ranking of Value Added Resellers of ERP Software is ... opportunities they are presented with. This honor represents the second such award in 2015 ...
(Date:7/28/2015)... ... July 28, 2015 , ... Carol McFarland, PT, PhD, ... and demonstration of specific rehabilitation exercises and treatment protocols in the PTA OT ... with an extensive interview conducted by Carol with a board certified neurosurgeon. Specific ...
(Date:7/28/2015)... ... July 28, 2015 , ... Cupertino orthodontist , ... revolutionary orthodontic treatment that allows patients to straighten teeth even without braces. “The ... imaging technology. You wear each set of aligners for about two weeks, removing ...
(Date:7/27/2015)... N.J. (PRWEB) , ... July 28, 2015 , ... Almost ... health plans to offer behavioral health counseling for persons who are obese and those ... happen was less clear. , That mandate will affect any commercial health plan with ...
(Date:7/27/2015)... ... July 27, 2015 , ... Specific cardiovascular risk factors, such ... volumes that may be early indicators of Alzheimer’s disease and dementia, according to ... vascular risk factors damage the brain and can result in cognitive impairment,” said ...
Breaking Medicine News(10 mins):Health News:Intellitec Solutions Named by Accounting Today as Top 100 Value Added Reseller 2Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 2Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 3Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 4Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 5Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 6Health News:Cupertino Invisalign Dentist, Dr. Setareh Mozafari, is Now Offering Complimentary Consultations for Invisalign 2Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 2Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 3Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 2Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 3
... affect brain function in adults who have few or ... results of the first study to examine cognitive functioning ... funded by the National Heart, Lung, and Blood Institute ... brain function scores and imaging tests in adult patients ...
... lead to future treatments, researchers say , TUESDAY, May ... that are linked to Alzheimer,s disease and could become ... Genetic variants appear to play an important part in ... with the disease increases a person,s risk. It is ...
... out of every ten pregnant women in the United States are ... the May issue of the American Journal of Obstetrics and ... pregnancy, the study shows that higher doses may be needed for ... Denver School of Medicine, lead author of the study said, "We ...
... facts and don,t recognize the symptoms, U.S. survey reveals , TUESDAY, ... women finds only about one in four women aged 25 to ... , This is important because researchers say it takes longer for ... a stroke, and researchers think lack of awareness about symptoms may ...
... ... hierarchically rather than serially, to deliver highly responsive, customer-oriented presentations. , ... London, UK (PRWEB) ... Designer is now available for Microsoft® Office PowerPoint®. This new software enables ...
... 11, 2010 Complex issues in interventional cardiology ... lab will be the focus of the 19th Annual ... DC. The symposium is being held in conjunction with ... of the Cardiovascular Research Foundation. "Changes are occurring ...
Cached Medicine News:Health News:New study suggests sickle cell disease may affect brain function in adults 2Health News:New study suggests sickle cell disease may affect brain function in adults 3Health News:New Alzheimer's Risk Genes Identified 2Health News:New Alzheimer's Risk Genes Identified 3Health News:Many pregnant women not getting enough vitamin D 2Health News:Women Often Miss Signs of Stroke 2Health News:GMARK Launches World's First Web-Like, PowerPoint Navigation Software 2Health News:Nurse/tech symposium at TCT 2010 will address complex issues in the cardiac cath lab 2
... enzymatic cleaner is a fast-acting ... stubborn deposits in as little ... enzymatic cleaner contains an enzyme ... film on soft contact lenses ...
... These specialty Eraser instruments have been ... with the right tool for situations ... a series of 25 gauge intraocular, ... discrete treatment of target tissues for ...
Wet-Field Hemostatic Eraser bipolar tip, packsize is 10/box....
Sterile cordless eraser tips, packsize is 10/box....
Medicine Products: